Loading the security page…
NYSE American · CCEL
Prices delayed by 15 minutes
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 May 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Cryo-Cell International, Inc. (CCEL) is a company in the Health care sector; its shares trade on NYSE American.
The price of Cryo-Cell International, Inc. (CCEL) on October 30, 2026 is 5.00 $, −3.57 % on the day. Over the past year the price changed by −19.78 %. Market capitalization is 40.31 million $, rank 7 among 9 stocks of the same industry with a known capitalization.
Cryo-Cell International, Inc. trades on NYSE American under the ticker CCEL. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks CCEL has traded between 2.72 $ and 4.90 $. As of 30 October 2026 the price stood 42.66 % of the way from the 52-week low to the high.
Over one year CCEL shares fell 19.78 %; over six months they rose 0.83 %. Volatility over 90 days is 95.24 %. Dividends are not included: this is price change only, as of 30 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 1.3, below the sector median of 3.6. Calculated from reports for the period ending 31 May 2026.
Cryo-Cell International, Inc. reported revenue of 31M $ and a net loss of 2M $ over the last four quarters. Net margin is −7.92 %. Revenue changed by −2.69 % year over year. Earnings per share are −0.31 $. Market capitalisation is 40M $.